|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
|
AU724399B2
(en)
|
1995-08-18 |
2000-09-21 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6773707B1
(en)
|
1995-08-18 |
2004-08-10 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6017540A
(en)
*
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
EP1336621B1
(en)
*
|
1997-08-05 |
2006-05-24 |
Stressgen Biotechnologies Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
AU2005201826B2
(en)
*
|
1997-08-05 |
2008-01-17 |
Nventa Biopharmaceuticals Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
ATE231917T1
(de)
|
1997-08-05 |
2003-02-15 |
Stressgen Biotechnologies Corp |
Immunresponse gegen hpv antigene erregt von zusammensetzungen die ein hpv antigen und ein stressprotein enthalten oder einen expressionsvektor fähig zur expression dieser proteine
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
ES2439014T3
(es)
|
1998-02-20 |
2014-01-21 |
The University Of Miami |
Complejo de péptido antigénico-proteína de choque térmico modificada
|
|
US6797480B1
(en)
|
1998-10-05 |
2004-09-28 |
University Of Connecticut Health Center |
Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents
|
|
AUPQ233799A0
(en)
|
1999-08-19 |
1999-09-09 |
Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales |
Recombinant sub-unit vaccine
|
|
GB9919733D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Colaco Camilo |
Vaccines against intracellular pathogens
|
|
US7378096B2
(en)
|
1999-09-30 |
2008-05-27 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
WO2001023421A2
(en)
|
1999-09-30 |
2001-04-05 |
Corixa Corporation |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
AU6669401A
(en)
|
2000-06-02 |
2001-12-11 |
Univ Connecticut Health Ct |
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
|
PL375043A1
(en)
|
2001-08-20 |
2005-11-14 |
University Of Connecticut Health Center |
Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin, useful for the treatment of cancer and infectious disease
|
|
WO2003029419A2
(en)
|
2001-10-01 |
2003-04-10 |
Duke University |
Three dimensional structure of crystalline grp94 binding domain, and its methods of use
|
|
AU2003231098A1
(en)
*
|
2002-04-25 |
2003-11-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US7420037B2
(en)
|
2003-02-13 |
2008-09-02 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
DE602004030541D1
(de)
|
2003-02-20 |
2011-01-27 |
Univ Connecticut Health Ct |
Verfahren zur herstellung von alpha (2) makroglobulin-antigen-molekül-komplexen
|
|
ATE553113T1
(de)
|
2003-02-28 |
2012-04-15 |
Agenus Inc |
Verwendung von lektinen zur förderung der oligomerisierung von glycoproteinen und antigenen molekülen
|
|
US7309491B2
(en)
|
2003-04-11 |
2007-12-18 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
EP2289547B1
(en)
|
2003-09-12 |
2015-12-16 |
Agenus Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
|
EP2257301B1
(en)
|
2008-03-03 |
2014-01-22 |
The University of Miami |
Allogeneic cancer cell-based immunotherapy
|
|
AU2009226077B2
(en)
|
2008-03-20 |
2012-04-19 |
University Of Miami |
Heat shock protein gp96 vaccination and methods of using same
|
|
AU2010232490B2
(en)
|
2009-04-03 |
2016-08-11 |
Agenus Inc. |
Methods for preparing and using multichaperone-antigen complexes
|
|
GB0910591D0
(en)
*
|
2009-06-19 |
2009-07-29 |
Immunobiology Ltd |
Method for the purification of protein complexes
|
|
GB0916557D0
(en)
|
2009-09-21 |
2009-10-28 |
Health Prot Agency |
Commensal neisserial stress protein complexes
|
|
KR20170109582A
(ko)
|
2015-02-06 |
2017-09-29 |
히트 바이오로직스, 인코퍼레이티드 |
벡터 공동 발현 백신 및 공동 자극 분자
|
|
EP3294324A1
(en)
|
2015-05-13 |
2018-03-21 |
Agenus Inc. |
Vaccines for treatment and prevention of cancer
|
|
CA3040123A1
(en)
|
2016-10-11 |
2018-04-19 |
University Of Miami |
Vectors and vaccine cells for immunity against zika virus
|
|
US11548930B2
(en)
|
2017-04-04 |
2023-01-10 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
KR20210005646A
(ko)
|
2018-04-26 |
2021-01-14 |
아게누스 인코포레이티드 |
열쇼크 단백질-결합 펩티드 조성물 및 그의 이용 방법
|